TriNetX & Harvard Pilgrim Health Care Institute Partner on FDA Sentinel System to Monitor COVID-19 Drug Usage
COVID-19 Clinical Real-World Data Being Utilized to Monitor for Potential Drug Shortages Cambridge, MA, May 21, 2020 — TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world...
Brazil’s Largest Real-World Dataset Available on the TriNetX Network Through a Partnership with Techtrials
Complements Existing Data from Brazil’s Leading Healthcare Organizations to Drive Clinical Research and Region-Specific Clinical Trials
TriNetX Taps Cohort of 66,700 Patients, Finds More Stroke Victims Among COVID-19 Patients Aged 30-50
Findings Lend Weight to Alarming Observations by Mount Sinai Physicians
Synteract Leverages the TriNetX Platform and COVID-19 Rapid Response Network to Find and Enroll Patients for Coronavirus Clinical Trials
Cambridge, MA, April 23, 2020 — TriNetX, the global health research network, launched a COVID-19 Rapid Response Network to enable the pharmaceutical community to design clinical trials with real-world data, and to quickly engagehealthcare organizations (HCOs) that...
Cambridge, MA, March 31, 2020 — TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE), has extended its global network into Japan with a just announced partnership...
TriNetX Readies its Real-World Data Platform and Global Network of Healthcare Organizations to Support COVID-19 Clinical Research
COVID-19 Clinical Data Now Available in the TriNetX Network, Enabling Rapid Monitoring to Study Efficacy and Safety of Fast-Tracked Therapies at Global Scale